🍪 CompoundTalk uses cookies to improve your experience, analyze traffic, and personalize content. By continuing to use this site, you agree to our Cookie Policy.
Evidence-based GLP-1 & peptide discussion since 2023
ForumsClinical Trials & ResearchEcnoglutide, mazdutide, and other emerging GLP-1 pipeline agents Page 4

Ecnoglutide, mazdutide, and other emerging GLP-1 pipeline agents

TrialTracker_MD Mon, Mar 9, 2026 at 9:47 AM 19 replies 418 viewsPage 4 of 4
DebRD_ATL
Senior Member
1,678
7,890
Feb 2024
Atlanta, GA
Mar 9, 2026 at 3:27 PM#16

Just wanted to say — for anyone reading this Ecnoglutide, thread who is feeling discouraged: it gets better. The first month are the hardest. Hang in there. 💪

20 15BiostatsBrad, PeptideSynthNJ, Dr.KarenChen and 17 others
Reply Quote Save Share Report
Dr.AddMedPHL
Senior Member
1,234
6,234
Mar 2024
Philadelphia, PA
Mar 9, 2026 at 3:44 PM#17

As a pharmacist, I want to add some clinical context to this discussion on Ecnoglutide, mazdutide, and other.

Building on what pete_manc_UK said — the evidence base here is robust. The key publications to reference are from the SUSTAIN program[1].

Key clinical points:

  1. Efficacy is dose-dependent and typically requires 4-5 weeks to reach steady state
  2. Side effect profile is predictable and usually manageable with standard protocols
  3. Monitoring should include baseline labs and follow-up at 3-month intervals
  4. Patient education significantly improves outcomes and adherence

Standard disclaimer: this is educational, not individualized medical advice.

References:
[1] See thread title for relevant study identification.
14 11sarah_nash92, FitDadDave, RunnerRach and 11 others
Reply Quote Save Share Report
Dr.CardioMD
VIP Member
2,678
14,567
Dec 2023
Cleveland, OH
Mar 9, 2026 at 4:01 PM#18
DebRD_ATL said:
The first month are the hardest

Gonna push back on this one. Ecnoglutide, mazdutide, and other is not that straightforward in my experience. I have been on this for 12 months and the reality is messier than the trials suggest.

Don't get me wrong — the medication works. But cost accessibility is a real barrier. We should be honest about that.

37 11tony_orlando, Dr.NephBHM_UK, kim_atl_prep and 34 others
Reply Quote Save Share Report

PeptideMeter — Independent Peptide Analytics

Community-driven peptide testing and vendor rating platform. Transparent results. Unbiased analysis. Trusted by thousands.

View Results
InsuranceTom
Senior Member
1,345
7,890
Mar 2024
Connecticut
Mar 9, 2026 at 4:18 PM#19

Can confirm — same results here.

Last edited: Mar 9, 2026 at 9:18 PM
22 22matt_MKE, Dr.ReproEndo, lucas_SP_BR and 19 others
Reply Quote Save Share Report
PharmacoVig_BOS
Senior Member
1,567
8,901
Feb 2024
Boston, MA
Mar 9, 2026 at 4:35 PM#20

Reading this thread on Ecnoglutide, mazdutide, hits close to home. Night shift nurse — I started at 295 lbs and felt like I would tried everything.

11 months on tirz and I am a different person. Not just the 70 lbs lost — my energy, my mood, my relationship with food. All transformed.

If you are on the fence about Ecnoglutide, — take the leap. It was the best health decision I have ever made. ❤️

15 24LabKate, kate.chem, DataDave and 12 others
Reply Quote Save Share Report

Similar Threads

FLOW trial: semaglutide renal outcomes — NEJM publication review14 replies
SELECT trial: semaglutide 2.4mg cardiovascular outcomes — 4yr data9 replies
TRIUMPH program (retatrutide) — Phase 3 trial design and endpoints13 replies
Orforglipron ATTAIN trials — oral non-peptide GLP-1 agonist8 replies
CagriSema (amylin + semaglutide) — REDEFINE Phase 3 results20 replies
ForumsNewTrendingMembersAccount

Log In

Forgot password?
No account? Register